Related Experiment Video
Updated: May 17, 2026

Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
Determinants of fitness to drive in Huntington disease
Hannes Devos1, Alice Nieuwboer, Mark Tant
1Department of Rehabilitation Sciences, Belgian Road Safety Institute, Brussels, Belgium. Hannes.Devos@faber.kuleuven.be
Insights
Half of Huntington disease (HD) drivers fail fitness to drive (FTDr) evaluations. A clinical screening tool accurately identifies at-risk drivers, improving road safety.
Area of Science:
- Neuroscience
- Neurology
- Transportation Safety
Background:
- Huntington disease (HD) significantly impacts cognitive and motor functions.
- Assessing fitness to drive (FTDr) in HD patients is crucial for public safety.
- Current screening methods for HD drivers may not be sufficiently accurate.
Purpose of the Study:
- To identify the most accurate clinical predictors of fitness to drive (FTDr) in Huntington disease (HD).
- To develop a reliable clinical screening tool for identifying HD patients at risk of driving impairment.
Main Methods:
- Cross-sectional study of 60 active drivers (30 HD patients, 30 controls).
- Utilized a clinical battery including cognitive tests (UHDRS, TMT, MMSE) and a driving simulator.
- Compared clinical predictors and neurologist appraisal against official FTDr evaluations.
Main Results:
- HD patients performed worse than controls on all assessments.
- 50% of HD patients failed the FTDr evaluation.
- A model using Symbol Digit Modalities Test, Stroop, and Trail Making Test B predicted FTDr with 87% accuracy.
Conclusions:
- Half of active drivers with HD are unfit to drive, posing a road hazard.
- A clinical screening tool can accurately identify HD drivers at risk.
- This tool can enhance road safety by proactively identifying impaired drivers.
Objectives:
To identify the most accurate clinical predictors of fitness to drive (FTDr) in Huntington disease (HD).
Methods:
This cross-sectional study included 60 active drivers: 30 patients with manifest HD (8 women) and 30 age- and gender-matched healthy controls. Mean (SD) age of the HD group was 50 (12) years and median (Q1-Q3) disease duration was 24 (12-48) months. A clinical battery consisting of a driving history questionnaire, the cognitive section of the Unified Huntington's Disease Rating Scale (UHDRS), Trail Making Test, and Mini-Mental State Examination, as well as a driving simulator evaluation, were administered to all participants. Additionally, the subjects with HD completed the motor, behavioral, and Total Functional Capacity sections of the UHDRS and underwent an official FTDr evaluation comprising visual, neuropsychological, and on-road tests. The blinded neurologist's appraisal of FTDr and the 3 most predictive clinical tests were compared with the official pass/fail FTDr decision.
Results:
The patients with HD performed worse on all tests of the clinical battery and driving simulator than the healthy controls. Fifteen patients with HD (50) failed the FTDr evaluation. The blinded neurologist correctly classified 21 patients (70%). The Symbol Digit Modalities Test, Stroop word reading, and Trail Making Test B provided the best model (R(2) = 0.49) to predict FTDr, correctly classifying 26 patients (87%).
Conclusions:
Half of active drivers with HD fail a driving evaluation and pose a potential hazard on the road. Our results suggest that those at risk can be accurately identified using a clinical screening tool.
More Related Videos
Related Concept Videos
Huntington Disease l: Introduction
Parkinson Disease l: Introduction
Genetic Lingo
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview

